Nino Giguashvili, Senior Research Analyst, IDC Health Insights Europe
The rapidly approaching deadline in the European Union's Falsified Medicines Directive (FMD) for drug serialization and traceability is currently the top concern of life science companies supplying pharmaceutical products to European markets.
European life sciences companies need to act immediately, and invest in serialization and information management solutions to avoid delays in compliance and the related penalties. However, they can (and should) take a more proactive approach to compliance-triggered digital investments, and capitalize on this opportunity to upgrade their digital systems and operations and derive longer-term business value for their supply chains.
In this webinar, an IDC Health Insights analyst will discuss the imperatives for digital transformation in European supply chains and the broader potential of the 3rd platform and innovation accelerator technologies to help life science companies achieve "smart compliance," and turn their supply chains into a source of competitive advantage through the adoption of IDC's STAR(S)2 approach.
About the Speaker:
Nino Giguashvili is Senior Research Analyst for IDC Health Insights Europe. Her core research covers ICT developments in the healthcare and life science industries of the region, analyzing key technology and business issues facing healthcare and public health organizations, pharmaceutical companies, and their ICT vendors, and offering in-depth insights into the primary factors shaping the industry in the region. She advises industry organizations and ICT vendors on planning and implementing effective digital health transformation initiatives to drive business innovation.